Latest Asx Market Updates News

Galilee Energy has raised the drilling derrick at its Zydeco-1 well in Louisiana, marking the last major pre-spud milestone. Drilling is set for early July 2026, aiming at a substantial Gulf Coast gas-condensate resource with rapid commercialisation potential.

Manuka Resources has secured the final US$4 million tranche of its US$30 million Nebari facility, fueling its push to restart gold production at Mt Boppy and silver output at Wonawinta by September 2026.

WT Financial Group (ASX: WTL) reports robust half-year growth and unveils a $3 billion equity partnership strategy to scale Australia’s largest financial adviser network.

Pursuit Minerals has kicked off fieldwork at its Sascha Marcelina gold-silver project in Argentina, confirming a significant mineralised system and preparing for a maiden drilling program.

St Barbara Limited forecasts a sharp rise in gold production to 191 koz by FY30, driven by the New Simberi expansion, Touquoy Restart, and 15-Mile Processing Hub. The company is well-capitalised with over A$500 million in cash and committed capital expenditure plans.

Collins Foods has formalised a settlement deed to resolve a long-running employee class action over 10-minute rest breaks, with Federal Court approval still pending.

ClearVue Technologies slashed its quarterly cash burn by 52.7%, trimming $6.9 million in annual costs, as it pushes forward with multiple international solar projects and key product certifications.

Harvest Technology Group is sharpening its focus on defence markets following an independent review that validates its Nodestream platform’s relevance. The company has initiated third-party validation and made significant leadership changes, including the CEO’s departure.

ARC Funds Limited’s trading suspension has been lifted following key announcements about new board appointments, signaling a fresh chapter for the investment manager.

ARC Funds Limited has been suspended from ASX trading due to a failure to maintain the minimum number of directors required by law, raising questions about its governance and future compliance.

Immutep Limited’s shares have resumed trading following the release of an interim futility analysis from its pivotal TACTI-004 Phase III trial of eftilagimod alfa.

Betashares Capital Ltd has announced the Distribution Reinvestment Plan (DRP) issue prices for its February 2026 distribution period, covering two of its popular ETFs. Investors must act quickly to participate before the early March deadline.